Most life sciences companies plan to significantly step up their use of real-world data sources over the next three years, according to a new survey by the Tufts Center for the Study of Drug Development.
In the second report from the 2017 eClinical Landscape Study, one of the largest, most in-depth surveys of clinical data management professionals, ninety-seven percent of companies polled said they plan to increase their use of at least one source of clinical data to improve the accuracy of their decisions in the development process. Ninety-eight percent of respondents, however, report challenges with their clinical data management systems, indicating a greater need to prepare as they anticipate growth.
The majority of data companies currently gather is from electronic case report forms. But most respondents said they plan to source more data from electronic patient reported outcomes and electronic clinical outcomes assessments — two sources that currently account for only 4 percent of the data they manage.